SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. I: In Vitro StudiesEric Bignon, Gérard Le Fur, Christophe Petereau et al.|Journal of Pharmacology and Experimental Therapeutics|1999Cited by 36
SR142948A is a Potent Antagonist of the Cardiovascular Effects of NeurotensinPaul Schaeffer, Jean‐Marc Herbert, M.-Cl. Laplace et al.|Journal of Cardiovascular Pharmacology|1998Cited by 27
Detection of bradykinin B1 receptors in rat aortic smooth muscle cellsPaul Schaeffer, Jean-Marc Herbert, Marie-Claude Laplace et al.|Biochemical Pharmacology|2001Cited by 17
Neurotensin induces the release of prostacyclin from human umbilical vein endothelial cells in vitro and increases plasma prostacyclin levels in the ratPaul Schaeffer, Jean‐Marc Herbert, Marie-Claude Laplace et al.|European Journal of Pharmacology|1997Cited by 15
CCK‐JMV‐180 acts as an antagonist of the CCK<sub>A</sub> receptor in the human IMR‐32 neuroblastoma cell linePaul Schaeffer, Jean Marc Herbert, V. Prabonnaud et al.|FEBS Letters|1994Cited by 6